CDS Rules and CQM for Classic MU2Tips and discussion related to building Clinical Decision Support Rules for MU2Please reference the accompanying Webinar located at

https://healthland.webex.com/healthland/lsr.php?RCID=707e6d5949d144668c6eeca6aafdb9e6

04/19/2023 CONFIDENTIAL |

A Tour Through Central Station

2

04/19/2023 CONFIDENTIAL | 3

04/19/2023 CONFIDENTIAL | 4

Upcoming Educational Opportunities

• Virtual - Meaningful Use Stage 2 Best Practices Friday June 6th at 1pm – Includes Meaningful Use Manager Dash Board view and CCDA – This class is 2 hours

• Virtual - Classic Eligible Hospital – Meaningful Use Stage 2 Core Set Measures Offered 3 separate times: Tuesday June 17th at 10am, June 19th at 10am and June 25th at 10am. This class is 3 hours

• Virtual – Classic Eligible Hospital Meaningful Use Stage 2 Menu Set and Clinical Quality Measures: Tuesday June 24th at 10am, Thursday June 26th at 10am and Monday, June 30th. This class is 3 hours

• Register on Central Station. If class is not listed, email centralstation@healthland.com or

• Reminder: This schedule may change without notice. Always check Central Station for the most accurate information

04/19/2023 CONFIDENTIAL | 5

Core Measure #5 Clinical Decision Support

(1) Implement 5 clinical decision support interventions related to 4 or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period.

6

Core Measure #5 Clinical Decision Support

Absent four clinical quality measures related to EH or CAH patient population, CDS interventions must be related to high-priority health conditions. It is suggested that one of the 5 CDS interventions be related to improving healthcare efficiency

7

Core Measure #5 Clinical Decision Support Part 2(2) The eligible hospital or CAH has enabled the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period

8

04/19/2023 CONFIDENTIAL | 9

Comparison to Stage 1

• Increased number of Clinical Decision Support rules from 1 to 5

• Added Drug-Drug and Drug-Allergy criteria to this measure

• Continues to be Self-Attestation

• No third party software required (However, if utilizing Problem List, would utilize SNOMED-CT codes for previous/current medical history)

04/19/2023 CONFIDENTIAL | 10

Tips for creating 5 CDS rules for MU2

• All 5 Clinical Decision Support rules should be active for the ENTIRE reporting period

• Take a screen shot of the CDS rule when created and activated. Retain to attach/upload for the Attestation process

• Screen Shots can be attached to the Meaningful Use Manager Dashboard

16 CQM’s Supported by Healthland

04/19/2023 CONFIDENTIAL | 11

• ED1 – Median Time from ED Arrival to ED Departure for Admitted ED Patients

• ED2 – Median Admit Decision Time to ED Departure Time for Admitted Patients

• ED3 – Median Time from ED Arrival to ED Departure for Discharged ED Patients *New*

• Stroke2 – Discharged on Antithrombotic Therapy• Stroke3 – Anticoagulation Therapy for Atrial Fibrillation/Flutter• Stroke4 – Thrombolytic Therapy• Stroke5 – Antithrombotic Therapy by End of Hospital Day 2• Stroke6 – Discharged on Statin Medication• Stroke8 – Stroke Education• Stroke10 – Assessed for Rehabilitation

16 CQM’s Support by Healthland

04/19/2023 CONFIDENTIAL | 12

• VTE1 – VTE Prophylaxis• VTE2 – Intensive Care Unit VTE Prophylaxis• VTE3 – VTE Patients with Anticoagulant Overlap Therapy• VTE4 – VTE Patients Receiving Unfractionated Heparin with

Dosages/Platelet Count Monitoring by Protocol• VTE5 – VTE Discharge Instruction• VTE6 – Incidence of Potential Preventable VTE

04/19/2023 CONFIDENTIAL |

Clinical Decision Support Set-Up

13

• Set-Up #1 – CDS rules based on or more of the following variables: Problem List, Medication List, Medication Allergy List, Demographics, Lab Results, Vital Signs, Department Orders

• Go to IS Administration>Maintenance>Rules Alert Maintenance>New

• Variables:• Demographics

• Medications

• Allergies

• Lab results

• Diagnosis (Problem List)

• Med Allergies

• Vital Signs

04/19/2023 CONFIDENTIAL |

Clinical Decision Support Set-Up

14

• Set-up #2 – Turn on Drug to Drug and Drug to Allergy Interaction Checking • Go to Pharmacy Maintenance>Setup Maintenance>MediSpan

Settings tab

• Perform Drug to Drug Interaction Checking field, Set to Y

• Perform Drug to Allergy Interaction Checking field, Set to Y

• In the Allergy Severity Filter field, select the desired setting for severity This setting must be set to moderate or higher. Default is set to Major

Additional items of note:

• Ensure that users have the appropriate user permissions in IS Administration>Maintenance>User Security Maintenance

• Previously built CDS rules utilizing ICD-9 codes should be converted to SNOMED-CT codes as the problem list will be utilizing SNOMED-CT

04/19/2023 CONFIDENTIAL | 15

04/19/2023 CONFIDENTIAL | 16

04/19/2023 CONFIDENTIAL |

User Guide is your friend!

17

• Healthland Classic Meaningful Use Stage 2 User Guide is your guide to:1. Measure Definition

2. Details of how we are capturing the Numerator and Denominator

3. Exclusions (if any)

4. Module and Data Elements Used in the software to capture information/data

5. Set Up Required

6. Comparison to Stage 1

7. 3rd Party Software required

8. Trouble shooting/Tips and Notes

Monitor for Updates to the Guide

Questions?